NDC 80777-100

Spikevax

Covid-19 Vaccine, Mrna

Spikevax is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Moderna Us, Inc.. The primary component is Elasomeran.

Product ID80777-100_8483facf-1d72-4de3-ac81-eedc517bac1b
NDC80777-100
Product TypeVaccine
Proprietary NameSpikevax
Generic NameCovid-19 Vaccine, Mrna
Dosage FormInjection, Suspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2022-04-01
Marketing CategoryBLA /
Application NumberBLA125752
Labeler NameModerna US, Inc.
Substance NameELASOMERAN
Active Ingredient Strength0 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 80777-100-98

10 VIAL in 1 CARTON (80777-100-98) > 7.5 mL in 1 VIAL (80777-100-15)
Marketing Start Date2022-04-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Spikevax" or generic name "Covid-19 Vaccine, Mrna"

NDCBrand NameGeneric Name
61434-043SPIKEVAXCOVID-19 Vaccine, mRNA
80777-100SpikevaxCOVID-19 Vaccine, mRNA
0069-2025ComirnatyCOVID-19 Vaccine, mRNA

Trademark Results [Spikevax]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SPIKEVAX
SPIKEVAX
97037862 not registered Live/Pending
ModernaTx, Inc.
2021-09-21
SPIKEVAX
SPIKEVAX
90247367 not registered Live/Pending
ModernaTx, Inc.
2020-10-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.